Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)

Clinical trial NCT00392678 · COMPLETED

Trial details

NCT number: NCT00392678
Sponsor: Joslin Diabetes Center
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2006-10-01
Primary completion: 2008-07-01
Enrollment: 277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.